会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • BALANCED MYRISTATE- AND LAURATE-CONTAINING EDIBLE OIL
    • 平衡含糖和含莴苣的可食用油
    • WO2011106618A8
    • 2012-09-13
    • PCT/US2011026203
    • 2011-02-25
    • UNIV BRANDEISPERLMAN DANIELHAYES KENNETH C
    • PERLMAN DANIELHAYES KENNETH C
    • A23D7/00A23D9/00A23L1/29A23L1/30
    • A23D7/001A23D7/003A23D9/00A23K20/158A23L33/12A23V2002/00A61K31/20A61K31/201A61K45/06A61K2300/00A23V2250/1882A23V2200/3262A23V2250/186A23V2250/1872
    • Nutritional fat or oil-based compositions for increasing HDL cholesterol, decreasing total cholesterol (TC), LDL cholesterol and decreasing the LDL/HDL cholesterol ratio in human plasma are described. The compositions can advantageously include at least 10% of myristic acid and/or lauric acid in which at least 3% of said fatty acid composition is myristic acid and at least 3% is lauric acid; in some cases at least 1% by weight myristic acid and/or lauric acid is esterified at the sn-2 position in triglyceride molecules. The compositions also include between 5% and 40% by weight linoleic acid, and typically further include at least 10% by weight monounsaturated fatty acids and between 15% and 55% by weight total saturated fatty acids. The sum of weight percentages for saturated, monounsaturated and polyunsaturated fatty acids equals 100%. In desirable cases, the composition is substantially cholesterol-free. Also described are fat compositions and diets which are adapted to limit increases in blood triglycerides, total cholesterol, LDL, and VLDL, even in the presence of dietary cholesterol.
    • 描述了用于增加HDL胆固醇,降低总胆固醇(TC),低密度脂蛋白胆固醇和降低人血浆中LDL / HDL胆固醇比例的营养脂肪或油基组合物。 组合物可以有利地包括至少10%的肉豆蔻酸和/或月桂酸,其中至少3%的所述脂肪酸组合物是肉豆蔻酸,并且至少3%是月桂酸; 在一些情况下,至少1重量%的肉豆蔻酸和/或月桂酸在甘油三酯分子的sn-2位被酯化。 组合物还包括5重量%至40重量%的亚油酸,并且通常还包括至少10重量%的单不饱和脂肪酸和15重量%至55重量%的总饱和脂肪酸。 饱和,单不饱和和多不饱和脂肪酸的重量百分比之和等于100%。 在期望的情况下,组合物基本上不含胆固醇。 还描述了脂肪组合物和饮食,其适于限制血液甘油三酯,总胆固醇,低密度脂蛋白和VLDL的增加,即使在膳食胆固醇的存在下。
    • 4. 发明申请
    • SN-2 MYRISTATE-CONTAINING EDIBLE OIL
    • SN-2含有香料的食用油
    • WO2010027433A3
    • 2010-05-14
    • PCT/US2009004860
    • 2009-08-25
    • UNIV BRANDEISPERLMAN DANIELHAYES KENNETH C
    • PERLMAN DANIELHAYES KENNETH C
    • A23D7/00
    • C11C3/10A23D9/02A23L33/12
    • A nutritional fat or oil-based composition for increasing HDL cholesterol, decreasing LDL cholesterol and decreasing the LDL/HDL cholesterol ratio in human plasma is described. The composition can advantageously include at least 1 % by weight myristic acid esterified at the sn-2 position in triglyceride molecules, includes between 10% and 40% by weight linoleic acid, and further includes between 30% and 65% by weight oleic acid and between 15% and 40% by weight total saturated fatty acids. The ratio of sn-2 myristic acid to sn-2 palmitic acid is typically greater than 1 :1 and the sum of weight percentages for saturated, monounsaturated and polyunsaturated fatty acids equals 100%. In desirable cases, the composition is substantially cholesterol-free.
    • 描述了用于增加人血浆中HDL胆固醇,降低LDL胆固醇和降低LDL / HDL胆固醇比的营养型油或脂基组合物。 所述组合物可以有利地包含在甘油三酯分子中在sn-2位酯化的至少1重量%的肉豆蔻酸,包含10重量%至40重量%的亚油酸,并且还包含30重量%至65重量%的油酸和 按重量计15%至40%的总饱和脂肪酸。 sn-2肉豆蔻酸与sn-2棕榈酸的比例通常大于1:1,饱和,单不饱和脂肪酸和多不饱和脂肪酸的重量百分比之和等于100%。 在理想的情况下,该组合物基本上不含胆固醇。
    • 5. 发明申请
    • STABILIZATION OF OMEGA-3 FATTY ACIDS IN OIL-WATER EMULSIONS
    • 欧米茄-3脂肪酸在油水乳液中的稳定性
    • WO2009111516A2
    • 2009-09-11
    • PCT/US2009/035940
    • 2009-03-03
    • PERLMAN, Daniel
    • PERLMAN, Daniel
    • A23C9/158
    • A23C9/1528A23D7/003A23D7/0053A23V2002/00A23V2250/1882A23V2250/187A23V2250/1868A23V2250/202A23V2250/2042A23V2250/0604
    • A food or beverage composition suitable for human consumption includes an aqueous suspension such as cow's milk that has been supplemented and homogenized with an omega-3 fatty acid-containing supplementation oil, in which a supplementation oil includes a blend of an omega-3 fatty acid-containing enriching oil that has been combined and diluted with an oxidative stabilization oil, such as a low linoleic acid/high oleic acid-containing oxidative stabilization oil. As a result, the rate of oxidation of EPA/DHA fatty acids added to the aqueous suspension via the supplementation oil can be reduced substantially, e.g., at least two-fold or even much more compared to the rate of oxidation of an equal quantity of the same EPA/DHA fatty acid-containing enriching oil homogenized into the same aqueous suspension without having been first combined and diluted with the oxidative stabilization oil.
    • 适合人类消费的食品或饮料组合物包括补充有ω-3脂肪酸的补充油补充和均化的牛奶等水性悬浮液,其中补充油包括ω-3脂肪酸的共混物 含有的富含油,其已经用氧化稳定油如低亚油酸/高含油酸的氧化稳定油组合和稀释。 结果,通过补充油添加到水性悬浮液中的EPA / DHA脂肪酸的氧化速率可以显着降低,例如相对于等量的氧化剂的氧化速率至少是两倍甚至更高 将相同的含有EPA / DHA脂肪酸的富集油均匀化成相同的水悬浮液,而不首先合并并用氧化稳定油稀释。